GlassScriptPhysician profile
David Paul Kimmel
NPI 1053306092
$2,179.95
in general payments reported to CMS, 2019-2025
23 companies · $39.52 in 2025
The $39.52 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $399 · 2021: $510 · 2022: $472 · 2023: $101 · 2024: $47.91 · 2025: $39.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $715.27 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $224.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $219.39 | 2019-2024 | Farxiga, Breztri |
| Pfizer INC. | $168.33 | 2019-2022 | |
| Mylan Specialty L.P. | $130.30 | 2020-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $124.37 | 2019-2022 | |
| Lilly USA, LLC | $81.81 | 2020-2021 | |
| Amgen INC. | $61.11 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $56.07 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.73 | 2019 | |
| Medtronic Minimed, INC. | $44.22 | 2020 | |
| Acadia Pharmaceuticals INC | $42.73 | 2022 | |
| Allergan, INC. | $30.99 | 2020 | |
| Glaxosmithkline, LLC. | $29.53 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.77 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.21 | 2022 | |
| Csl Behring | $26.03 | 2025 | Hizentra |
| Shire North American Group INC | $24.74 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.88 | 2019 | |
| Medtronic, INC. | $19.19 | 2021 | |
| Abbvie INC. | $16.40 | 2021 | |
| Exact Sciences Corporation | $16.21 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $15.74 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kimmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.